Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study.

By K.K. Teo, S. Ôunpuu, S. Hawken, M. Pandey, V. Valentín, D. Hunt, R. Diaz, W. Rashed, Rosario V. Freeman, Lixin Jiang and 2 more. The Lancet, 2006

923 citations recorded by the source corpus.

Subfields: Biochemistry, Pathology and Forensic Medicine, Physiology

View Paper: https://www.semanticscholar.org/paper/630df2684556d819a2b34eb0daa3e9826b9b43e2

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Biochemistry

1. E. Schiffrin

In Physiology

1. E. Schiffrin

Citations in the corpus

• The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. (2013, background): “Cigarette smoking is a well-established, independent, and powerful risk factor for vascular disease.(119) Smoking cessation is thus a critically important component of global vascular risk reduction in hypertensive patients.”
• Growing Epidemic of Coronary Heart Disease in Low- and Middle-Income Countries (2010, background): “The combined use of different forms of tobacco is associated with a higher risk of AMI than use one type alone [68].”